Search - tctmd.com

Displaying 581 - 600 of 2263

Sort: Relevancy | Date

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Daily News

Payments to Docs Appear to Influence Implantable Device Selection

Michael O'Riordan

November 04, 2020

News Daily News

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

Caitlin E. Cox

October 29, 2020

News Daily News

New Review Urges Rethink of Cardiogenic Shock Care

Caitlin E. Cox

October 27, 2020

Direct Temsirolimus Delivery Shows Promise in BTK: Phase II Study

News Conference News TCT 2020

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

Todd Neale

October 18, 2020

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Conference News TCT 2020

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

L.A. McKeown

October 18, 2020

News Industry News

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

October 17, 2020

News Conference News TCT 2020

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

Michael O'Riordan

October 17, 2020

News Conference News TCT 2020

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

Shelley Wood

October 16, 2020

News Conference News TCT 2020

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

L.A. McKeown

October 15, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2020

Shelley Wood

October 01, 2020

News Daily News

Large UK Study Explores Use of Excimer Laser Coronary Atherectomy

Todd Neale

September 25, 2020

News Daily News

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

Caitlin E. Cox

September 23, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

Advertisement

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

Payments to Docs Appear to Influence Implantable Device Selection

DOACs May Up Post-TAVR Survival in A-fib: OCEAN-TAVI

New Review Urges Rethink of Cardiogenic Shock Care

Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study

FlowTriever Looks Good for Acute PE in Interim FLASH Results

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

IN.PACT BTK Provides Renewed Hope for Attacking CLI With DCBs

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

MitraClip Viable in MI Patients With Acute MR, Including Patients in Shock: IREMMI

MitraBridge: Could a MitraClip Help Patients Avoid Heart Transplant?

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

TCTMD’s Top 10 Most Popular Stories for September 2020

Large UK Study Explores Use of Excimer Laser Coronary Atherectomy

Clopidogrel Only Needed for 3 Months After ASD Closure: CANOA Analysis

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content